Betrixaban for prevention of venous thromboembolism in acute medically ill patients-Reference-Cited by-同舟云学术

Betrixaban for prevention of venous thromboembolism in acute medically ill patients

Published:2018-05-01 Issue:suppl_E Volume:20 Page:E16-E22
ISSN:1520-765X
Container-title:European Heart Journal Supplements
language:en
Short-container-title:

Author:

Beyer-Westendorf Jan¹²,Verhamme Peter³,Bauersachs Rupert⁴

Affiliation:

1. Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital “Carl Gustav Carus”, Technische Universität Dresden, Fetscherstrasse 74, Dresden, 01307, Germany

2. Kings Thrombosis Service, Department of Hematology, Kings College London, UK

3. Vascular Medicine and Haemostasis, Department of Cardiovascular Medicine, University Hospitals Leuven – KU Leuven, Herestraat 49, Leuven, 3000, Belgium

4. Vascular Medicine, Klinikum Darmstadt GmbH, Grafenstraße 9, 64283, Darmstadt, Germany

Funder

Portola Pharmaceuticals, Inc.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartjsupp/article-pdf/20/suppl_E/E16/25079966/suy017.pdf

Reference22 articles.

1. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients;Cohen;Thromb Haemost,2005

2. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality;Cohen;Thromb Haemost,2007